GDF15 and Familial prostate cancer: To assess the prognostic value of GDF15 expression in primary prostate cancer, we analyzed the Erho microarray dataset, which contains 545 radical prostatectomy samples with a median follow-up of 16.9 years [38], for association with clinicopathologic parameters.